Grupa Azoty (ATT) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
4 Sep, 2026Executive summary
Secured stabilizing agreements with financial institutions and extended standstill agreements to November 2025, supporting recovery and transformation efforts.
Announced a new strategy to 2030 and launched the AZOTY BUSINESS Programme, focusing on core business, cost optimization, and restructuring.
Initiated a two-stage share issue to recapitalize and fund investments, with proposals up to PLN 1.2 billion and state treasury share not to exceed 50%.
Received a non-binding offer from Orlen to acquire Grupa Azoty Polyolefins/Polyamid-6 for PLN 1.022 billion.
The Agro segment was the main revenue driver, while Plastics and Chemicals segments faced negative margins.
Financial highlights
Revenue for 9M 2025 was PLN 10,034.8 million, up 2.1% year-over-year.
EBITDA for 9M 2025 reached PLN 312.1 million (margin 3.1%), up from a loss in 2024, driven by a one-off gain from the Polimery Police/Polyamid-6 settlement.
Q3 2025 revenue was PLN 2.9 billion, down 6% year-over-year, mainly due to lower advanced chemicals sales.
Q3 2025 EBITDA was PLN 391 million (13.5% margin), a turnaround from a loss in Q3 2024, due to one-off events.
Net loss for 9M 2025 was PLN 1,027.5 million, widening from the previous year.
Outlook and guidance
Strategic focus on cost optimization, capital discipline, and business transformation to restore profitability.
Shareholder meeting scheduled for February 13, 2026, to approve share issue and further stabilize finances.
By 2030, targets include annual revenue of PLN 17–18 billion, EBITDA of PLN 1.9–2.0 billion, and net debt/EBITDA below 2.5x.
Effects of new tariffs on Russian fertilizers expected from January 2026, with further price increases possible in H2 2026.
The Group expects continued market volatility due to global trade tensions, energy prices, and geopolitical factors.
Latest events from Grupa Azoty
- Sales grew, but losses, market headwinds and financing uncertainty persisted.ATT
Q1 2025 - Q3 rebounded on a one-off settlement, but losses and financing risks persist.ATT
Q3 2025 - Agro-led EBITDA recovery paired with GAP restructuring targets a sharp debt reduction.ATT
Q4 2025 - EBITDA rebounded to PLN 316.5m, but funding risks and Polyolefins’ conditional sale remain.ATT
Q1 2026 - Q2 EBITDA rebounded, but financing and restructuring risks persist.ATT
Q2 2026 - Q2 EBITDA rebounded to PLN 294m as Chemicals and Agro strengthened.ATT
Q2 2026 - EBITDA surged to PLN 316.5 million as profitability improved and restructuring advanced.ATT
Q1 2026 - Revenue up 12.4% YoY; Agro leads growth, but net loss persists amid restructuring.ATT
Q1 2025 - EBITDA improved and net loss narrowed, supported by cost cuts and CapEx reduction.ATT
Q4 2024